AXSYM GENTAMICIN 7A65-20

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,04 report with the FDA on 2008-04-30 for AXSYM GENTAMICIN 7A65-20 manufactured by Abbott Diagnostics International, Ltd..

Event Text Entries

[853344] The customer contacted abbott after receipt of abbott's customer letter regarding axsym gentamicin reagent performance. The customer stated they had been using the reagent lot in question for quite a while and observed abbott quality controls quickly drifting out of range high. The abbott customer service representative requested the customer fax calibration and quality control data to abbott for data review. The customer stated the assay performance is acceptable after changing the lot of axsym gentamicin reagent and there was no impact to pt management.
Patient Sequence No: 1, Text Type: D, B5


[8060006] An investigation was conducted for the abbott axsym and tdx/tdxflx gentamicin reagents. The abbott axsym and tdx/tdxflx gentamicin reagents share the same antibody and tracer stock concentrates. A decrease in the calibrator a-f span was observed with the tdx/tdxflx gentamicin reagents resulting in tdx/tdxflx gentamicin calibration failures (span less than minimum span). Although there was an apparent decrease in the axsym gentamicin reagent calibrator a-f span, this issue did not result in a calibration failure. Nevertheless, individual replicates of the medium control level out of specification (oos) flags were generated during stability for two time points. For the axsym gentamicin reagent lots, since there was a potential the calibrator a-f span could result in calibration failures, a decision was made to reduce the expiration date for the axsym gentamicin reagents, however, the data from the investigation supports the axsym gentamicin reagent lots were not impacted and performed as expected. Stability testing monitored axsym gentamicin reagent until the last test point, which was one month beyond the reagent's expiration date. The calibrator a-f span did not continue to decrease; instead, it increased, supporting there was not a true decrease in calibrator a-f span for the axsym gentamicin reagent. With respect to the axsym gentamicin medium control oos results, none of the subsequent test points showed control oos until the last test point. Statistical eval (assay capability) along with these new test points support that replicates of medium control oos results were related to the expected assay variability, therefore, there were no preventive actions warranted for the axsym gentamicin assay.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2623532-2008-00011
MDR Report Key1036541
Report Source01,04
Date Received2008-04-30
Date of Report2008-04-07
Date of Event2007-11-05
Date Mfgr Received2008-04-07
Device Manufacturer Date2007-05-01
Date Added to Maude2009-08-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactSUDARSHAN HEBBAR, MD, D-3MQC, AP6B
Manufacturer Street100 ABBOTT PARK RD.
Manufacturer CityABBOTT PARK IL 600646112
Manufacturer CountryUS
Manufacturer Postal600646112
Manufacturer Phone8479379677
Single Use3
Remedial ActionOT
Previous Use Code3
Removal Correction Number2623532-11/7-07-009-C
Event Type3
Type of Report3

Device Details

Brand NameAXSYM GENTAMICIN
Generic NameFOR THE QUANTITATIVE MEASUREMENT OF GENTAMICIN IN SERUM OR PLASMA
Product CodeLCQ
Date Received2008-04-30
Model NumberNA
Catalog Number7A65-20
Lot Number53190Q100
ID Number58600Q100
Device Expiration Date2008-04-12
OperatorOTHER
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT DIAGNOSTICS INTERNATIONAL, LTD.
Manufacturer AddressKM 58.0, CARRETERA 2 CRUCE DAVILA BARCELONETA PR 00617 US 00617


Patients

Patient NumberTreatmentOutcomeDate
10 2008-04-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.